| Trial ID: | L1100 |
| Source ID: | NCT01572610
|
| Associated Drug: |
Rta 402
|
| Title: |
A Glomerular Filtration Rate (GFR) Measuring Study of RTA 402 in Chronic Kidney Disease (CKD) Patients With Type 2 Diabetes Mellitus
|
| Acronym: |
|
| Status: |
TERMINATED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Chronic Kidney Disease|Type 2 Diabetes
|
| Interventions: |
DRUG: RTA 402
|
| Outcome Measures: |
Primary: Efficacy: glomerular filtration rate measured by inulin clearance, Individual subjects' change from baseline in GFR measured by inulin clearance will be evaluated., Up to 16 weeks|Adverse Event collection and assessment, Adverse Event collection, Up to 16 weeks |
|
| Sponsor/Collaborators: |
Sponsor: Kyowa Kirin Co., Ltd.
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE2
|
| Enrollment: |
11
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2012-02
|
| Completion Date: |
2013-11
|
| Results First Posted: |
|
| Last Update Posted: |
2017-03-03
|
| Locations: |
Koga city, Ibaraki, Japan
|
| URL: |
https://clinicaltrials.gov/show/NCT01572610
|
